NEJM Evidence reports a small RCT where West Nile virus neutralizing plasma did not reduce 30-day death or functional decline compared with placebo in hospitalized patients.
This small RCT showed no difference in the rate of 30-day death or functional decline compared to placebo.
In patients hospitalized with West Nile virus (WNV) disease, does treatment with WNV-neutralizing plasma reduce unfavorable outcomes?
This small RCT showed no difference
compared to placebo.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare